324 related articles for article (PubMed ID: 24288045)
21. Current status of development of methylation biomarkers for in vitro diagnostic IVD applications.
Taryma-Leśniak O; Sokolowska KE; Wojdacz TK
Clin Epigenetics; 2020 Jul; 12(1):100. PubMed ID: 32631437
[TBL] [Abstract][Full Text] [Related]
22. DNA Methylation as a Noninvasive Epigenetic Biomarker for the Detection of Cancer.
Leygo C; Williams M; Jin HC; Chan MWY; Chu WK; Grusch M; Cheng YY
Dis Markers; 2017; 2017():3726595. PubMed ID: 29038612
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic diagnostics of cancer--the application of DNA methylation markers.
Paluszczak J; Baer-Dubowska W
J Appl Genet; 2006; 47(4):365-75. PubMed ID: 17132902
[TBL] [Abstract][Full Text] [Related]
24. Targeted deep sequencing of plasma circulating cell-free DNA reveals Vimentin and Fibulin 1 as potential epigenetic biomarkers for hepatocellular carcinoma.
Holmila R; Sklias A; Muller DC; Degli Esposti D; Guilloreau P; Mckay J; Sangrajrang S; Srivatanakul P; Hainaut P; Merle P; Herceg Z; Nogueira da Costa A
PLoS One; 2017; 12(3):e0174265. PubMed ID: 28333958
[TBL] [Abstract][Full Text] [Related]
25. Is Any Cardiovascular Disease-Specific DNA Methylation Biomarker Within Reach?
de la Rocha C; Zaina S; Lund G
Curr Atheroscler Rep; 2020 Aug; 22(10):62. PubMed ID: 32844297
[TBL] [Abstract][Full Text] [Related]
26. DNA methylation biomarkers of future health outcomes in children.
Shanthikumar S; Neeland MR; Maksimovic J; Ranganathan SC; Saffery R
Mol Cell Pediatr; 2020 Jul; 7(1):7. PubMed ID: 32642955
[TBL] [Abstract][Full Text] [Related]
27. Recent patents of DNA methylation biomarkers in gastrointestinal oncology.
Corvalan AH; Maturana MJ
Recent Pat DNA Gene Seq; 2010 Nov; 4(3):202-9. PubMed ID: 21073436
[TBL] [Abstract][Full Text] [Related]
28. The Bladder EpiCheck Test as a Non-Invasive Tool Based on the Identification of DNA Methylation in Bladder Cancer Cells in the Urine: A Review of Published Evidence.
Mancini M; Righetto M; Zumerle S; Montopoli M; Zattoni F
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911596
[TBL] [Abstract][Full Text] [Related]
29. DNA methylation in peripheral blood: a potential biomarker for cancer molecular epidemiology.
Li L; Choi JY; Lee KM; Sung H; Park SK; Oze I; Pan KF; You WC; Chen YX; Fang JY; Matsuo K; Kim WH; Yuasa Y; Kang D
J Epidemiol; 2012; 22(5):384-94. PubMed ID: 22863985
[TBL] [Abstract][Full Text] [Related]
30. DNA methylation as a biomarker in breast cancer.
Martens JW; Margossian AL; Schmitt M; Foekens J; Harbeck N
Future Oncol; 2009 Oct; 5(8):1245-56. PubMed ID: 19852739
[TBL] [Abstract][Full Text] [Related]
31. Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer.
Coppedè F; Lopomo A; Spisni R; Migliore L
World J Gastroenterol; 2014 Jan; 20(4):943-56. PubMed ID: 24574767
[TBL] [Abstract][Full Text] [Related]
32. Strategies for validation and testing of DNA methylation biomarkers.
Noehammer C; Pulverer W; Hassler MR; Hofner M; Wielscher M; Vierlinger K; Liloglou T; McCarthy D; Jensen TJ; Nygren A; Gohlke H; Trooskens G; Braspenning M; Van Criekinge W; Egger G; Weinhaeusel A
Epigenomics; 2014; 6(6):603-22. PubMed ID: 25531255
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic alterations as biomarkers in pancreatic ductal adenocarcinoma.
Syren P; Andersson R; Bauden M; Ansari D
Scand J Gastroenterol; 2017; 52(6-7):668-673. PubMed ID: 28301276
[TBL] [Abstract][Full Text] [Related]
34. DNA methylation biomarkers as diagnostic and prognostic tools in colorectal cancer.
Gyparaki MT; Basdra EK; Papavassiliou AG
J Mol Med (Berl); 2013 Nov; 91(11):1249-56. PubMed ID: 24057814
[TBL] [Abstract][Full Text] [Related]
35. Blood-Based DNA Methylation Biomarkers for Type 2 Diabetes: Potential for Clinical Applications.
Willmer T; Johnson R; Louw J; Pheiffer C
Front Endocrinol (Lausanne); 2018; 9():744. PubMed ID: 30564199
[TBL] [Abstract][Full Text] [Related]
36. DNA methylation profiles in cancer diagnosis and therapeutics.
Pan Y; Liu G; Zhou F; Su B; Li Y
Clin Exp Med; 2018 Feb; 18(1):1-14. PubMed ID: 28752221
[TBL] [Abstract][Full Text] [Related]
37. The potential use of DNA methylation biomarkers to identify risk and progression of type 2 diabetes.
Gillberg L; Ling C
Front Endocrinol (Lausanne); 2015; 6():43. PubMed ID: 25870586
[TBL] [Abstract][Full Text] [Related]
38. DNA Methylation Biomarkers for Nasopharyngeal Carcinoma: Diagnostic and Prognostic Tools.
Jiang W; Cai R; Chen QQ
Asian Pac J Cancer Prev; 2015; 16(18):8059-65. PubMed ID: 26745039
[TBL] [Abstract][Full Text] [Related]
39. Young women with poor ovarian response exhibit epigenetic age acceleration based on evaluation of white blood cells using a DNA methylation-derived age prediction model.
Hanson BM; Tao X; Zhan Y; Jenkins TG; Morin SJ; Scott RT; Seli EU
Hum Reprod; 2020 Nov; 35(11):2579-2588. PubMed ID: 33049778
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic biomarkers in esophageal cancer.
Kaz AM; Grady WM
Cancer Lett; 2014 Jan; 342(2):193-9. PubMed ID: 22406828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
